We are live on
!
Find out more
RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.7B
1-Year Est. Return
93.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.87%
1 Year Est. Return
+93.03%
3 Year Est. Return
+228.43%
5 Year Est. Return
+368.14%
10 Year Est. Return
+4,607.77%
AUM
$1.7B
AUM Growth
-$252M
(-13%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-9.43%
Top 10 Holdings %
Top 10 Hldgs %
40.6%
Holding
107
New
9
Increased
39
Reduced
24
Closed
6
Top Buys
| 1 |
MMED
MiniMed Group Inc
MMED
|
+$17.4M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
+$15M |
| 3 |
Boston Scientific
BSX
|
+$9.3M |
| 4 |
HTFL
Heartflow Inc
HTFL
|
+$8M |
| 5 |
PTC Therapeutics
PTCT
|
+$7.08M |
Top Sells
| 1 |
EXAS
Exact Sciences
EXAS
|
+$61.1M |
| 2 |
CDTX
Cidara Therapeutics
CDTX
|
+$45.3M |
| 3 |
FOLD
Amicus Therapeutics
FOLD
|
+$27.4M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$24M |
| 5 |
Travere Therapeutics
TVTX
|
+$21.9M |
Sector Composition
| 1 | Healthcare | 99.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDTX
101
DELISTED
Cidara Therapeutics
CDTX
| – | – |
-204,878
| Closed | -$45.3M |
|
|
EXAS
102
DELISTED
Exact Sciences
EXAS
| – | – |
-601,800
| Closed | -$61.1M |
|
|
MRSN
103
DELISTED
Mersana Therapeutics
MRSN
| – | – |
-152,586
| Closed | -$4.41M |
|
|
NUVB.WS
104
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
| – | – |
-134,028
| Closed | -$44.2K |
|
|
RAPT
105
DELISTED
RAPT Therapeutics
RAPT
| – | – |
-213,731
| Closed | -$7.24M |
|
106
Theravance Biopharma
TBPH
$877M
| – | – |
-208,771
| Closed | -$3.91M |
|
Similar funds
AAM
SGI
WAS
SI
PP
SWM
AAA
FDP